Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Levosimendan in CABG Patients With Impaired LV Function
NCT01318460Phase 4Completed
- Sponsor
- AHEPA University Hospital
- Start
- Mar 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan in coronary artery disease (CAD), sponsored by AHEPA University Hospital. Started Mar 2011; status: completed.
02
Drugs
levosimendan
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01318460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01318460.